The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis

Intensive Care Medicine
Henry J SilvermanEuropean Union Directive

Abstract

We perform an ethical analysis of European Union Directive 2001/20/EC on the simplification and harmonization of guidelines regarding good clinical practice in the conduct of clinical trials involving drugs. The Directive provides guidance on protecting incapacitated subjects who participate in drug clinical trials. Such guidance promotes society's obligations of beneficence because the participation of incapacitated subjects in research is crucial in advancing the understanding and treatment of serious diseases. The Directive requires proxy consent for incapacitated subjects which adheres to the principle of respect for persons. The Directive also recommends additional safeguards to further protect subjects against exploitation and harm. These include respect for the assent and dissent of incapacitated subjects and the "necessity" and "subject-condition" requirements. While these essential protection mechanisms are commendable, the Directive fails to endorse other safeguards that have been recommended by other research ethics guidelines, especially for riskier research. The Directive's silence regarding research in the emergency setting frustrates the principle of beneficence because the lack of guidance might prove to be a ba...Continue Reading

Citations

Feb 16, 2006·Intensive Care Medicine·Catherine ChenaudBara Ricou
Mar 16, 2007·Intensive Care Medicine·Magali CiroldiElie Azoulay
Jun 25, 2009·Intensive Care Medicine·Damon C ScalesNiall D Ferguson
Jul 3, 2013·Intensive Care Medicine·Damon C Scales
Jun 15, 2006·Wiener klinische Wochenschrift·Kathleen LiddellUNKNOWN Working Group of the Vienna Initiative to Save European Academic Research
May 22, 2008·Journal of Cross-cultural Gerontology·Gina BravoBruno Vellas
Jun 16, 2005·Resuscitation·David C Cone, Robert E O'Connor
Aug 9, 2006·American Journal of Respiratory and Critical Care Medicine·François Lemaire
Feb 24, 2007·Critical Care : the Official Journal of the Critical Care Forum·Robert D Truog
Sep 4, 2007·Critical Care : the Official Journal of the Critical Care Forum·Marcus J SchultzOgnjen Gajic
Oct 21, 2006·Intensive Care Medicine·Peter H J van der VoortJozef Kesecioglu
Jan 22, 2005·Intensive Care Medicine·Ernst A Singer, Christiane Druml
May 25, 2007·La Presse médicale·François LemaireChristian Brun-Buisson
Oct 13, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E-B van VeenJ W Oosterhuis
Apr 29, 2009·International Journal of Surgery·Raafat Y AfifiR David Rosin
Mar 24, 2015·Resuscitation·Spyros D MentzelopoulosGraham Nichol
May 13, 2009·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Roger J LewisUNKNOWN International Regulatory Status of Emergency Exception to Informed Consent Study Group
Dec 24, 2004·Current Opinion in Critical Care·Christiane Druml
Dec 24, 2004·Current Opinion in Critical Care·Didier Dreyfuss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.